Company Filing History:
Years Active: 2010-2017
Title: Rochdi Bouhelal: Innovator in Pharmaceutical Chemistry
Introduction
Rochdi Bouhelal is a notable inventor based in Buschwiller, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that act as agonists for nicotinic acetylcholine receptors.
Latest Patents
Rochdi Bouhelal holds 3 patents related to his innovative work. His latest patents include the invention of 1-aza-bicycloalkyl derivatives, which are designed to function as alpha 7 nicotinic acetylcholine receptor (nAChR) agonists. These compounds are crucial for their potential applications in pharmaceuticals, as they can be used in various therapeutic compositions.
Career Highlights
Throughout his career, Bouhelal has been associated with Novartis AG, a leading global healthcare company. His work has focused on the synthesis and application of complex chemical compounds that have the potential to address various medical conditions.
Collaborations
Rochdi Bouhelal has collaborated with esteemed colleagues, including Dominik Feuerbach and Konstanze Hurth. These partnerships have enhanced the research and development of his innovative pharmaceutical solutions.
Conclusion
Rochdi Bouhelal's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments.